Prevalence of atherosclerosis in patients with inactive rheumatoid arthritis

Pooneh Dehghan1, Alireza Rajaei, Reza Moeineddin

  • 1Department of Imaging, Taleghani Hospital, Shahid Beheshti University of Medical Sciences, Chamran Highway, Evin, Tehran, 1985717443, Iran, p.dehghan@sbmu.ac.ir.

Insights

Patients with inactive rheumatoid arthritis (RA) have increased subclinical atherosclerosis, indicated by higher common carotid artery intima-media thickness (CCA-IMT). Carotid ultrasonography can help assess cardiovascular disease risk in these patients.

Area of Science:

  • Cardiovascular Medicine
  • Rheumatology
  • Medical Imaging

Background:

  • Rheumatoid arthritis (RA) patients face elevated cardiovascular morbidity and mortality.
  • Subclinical atherosclerosis, a precursor to cardiovascular events, is a significant concern in RA.
  • Common carotid artery intima-media thickness (CCA-IMT) is a validated ultrasound marker for atherosclerosis.

Purpose of the Study:

  • To investigate the prevalence of subclinical atherosclerosis in patients with inactive rheumatoid arthritis.
  • To compare CCA-IMT and carotid plaque presence between RA patients and healthy controls.
  • To identify factors associated with abnormal CCA-IMT in RA patients.

Main Methods:

  • Ultrasound measurement of CCA-IMT at the carotid bifurcation in 35 RA patients and 35 matched controls.
  • Exclusion of participants with known cardiovascular risk factors.
  • Statistical analysis using independent t test and chi-squared test, adjusting for age, sex, RA duration, and medication.

Main Results:

  • Abnormal CCA-IMT was found in 25.7% of RA patients versus 5.7% of controls.
  • RA patients exhibited more carotid atherosclerotic plaques and higher mean CCA-IMT.
  • Abnormal CCA-IMT was more prevalent in RA patients over 50 years old with over 5 years of disease duration (P=0.001).

Conclusions:

  • Chronic inflammation in inactive RA is linked to atherosclerosis.
  • Carotid ultrasonography is a valuable tool for assessing cardiovascular disease risk in RA patients.
  • Early detection and management of atherosclerosis are crucial for RA patients.

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
1.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
767
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
904
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
592
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
511
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K